Loading clinical trials...
Loading clinical trials...
Browse 467 clinical trials for migraine. Find studies that match your criteria and connect with research centers.
Find trials near:
Showing 81-100 of 467 trials
NCT04211454
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
NCT06959004
Substance P is a neuropeptide implicated in the pathogenesis of headache. This study investigates whether its administration can trigger migraine attacks in individuals with migraine without aura.
NCT05337033
Chronic headaches are a major cause of disability among adolescents. Cannabis products have supported the management of headaches in adults and may play a role in pediatric chronic pain. We propose a multisite, open-label, tolerability study conducted across three centers in Canada of Cannabidiol-enriched Cannabis Herbal Extract in adolescents (ages 14 to 17 years old) with chronic headaches. The study includes a one month baseline assessment, four months of escalating treatment doses and a weaning period. Our primary outcome is tolerability defined as the number and severity of reported adverse events.